Fraunhofer Institute for Molecular Biology and Applied Ecology IME

Annual report 2017/2018

Read about our highlights of the past year

more info

Film about the Fraunhofer IME: "Natural Products for Biotechnology"

Insects are small creepy-crawlies with great potential - survival artists living in the most inhospitable places. How the molecules they produce enrich research and open up new perspectives for therapies, a new film is now showing.

more info

New strategies against mosquitoes and pests

Mosquitoes can transmit serious diseases; flies can cause massive crop failures. New strategies are envisioned to cope with such insect pests. Environmentally friendly and species-specific. In this context, the "Sterile Insect Technique" plays an important role.

more info

Rubber from dandelions

Scientists at the Westfälische Wilhelms-Universität Münster and the Fraunhofer IME identify key components of the rubber-biosynthesis

more info

Predicting pesticide loads more accurately

Fraunhofer IME researchers have developed a software for Germany estimating pesticide concentrations in surface waters. The new process can be employed as a component of pesticide authorization procedures

more info

Recycling of industrial exhaust gases

Fraunhofer researchers develop a process for the recycling of exhaust gases from industrial production facilities

more info

New testing concept using molecular markers

Fraunhofer scientists track endocrine disruption in fish using molecular markers

more info
 

Our locations

 

Molecular Biotechnology: Aachen | Münster

Applied Ecology and Bioresources: Schmallenberg | Gießen

Translational Medicine: Frankfurt a.M. | Hamburg

 

Research from molecule to ecosystem

 

Welcome to the Fraunhofer IME. We conduct research in the field of applied life sciences from a molecular level to entire ecosystems and are your partner for contract research in the areas of pharmacy, medicine, chemistry, agriculture, as well as environmental and consumer protection. Our research and development portfolio is focused on industry, small and medium enterprises and on the public sector.

The overarching goal of our research activities at Fraunhofer IME is the development and use of novel technologies for diagnosis and therapy of human and animal diseases as well as the protection of crop plants and food sources.

 

Our Research Divisions

The key areas of expertise of the Fraunhofer-Institute for Molecular Biology and Applied Ecology IME are spread over three divisions, all of which deal with the identification, production, specific application and evaluation of substances, ranging from biotechnological products to active agents for clinical applications.

 

Publications

 

You can find publication lists of the Fraunhofer IME, our annual reports, booklets and flyers here:

 

1.8.2018

License Agreement with LenioBio

 

Life sciences startup LenioBio GmbH and the Fraunhofer IME announced today the signing of an exclusive license agreement that allows LenioBio to utilize Fraunhofer’s proprietary vector solution and technology for the cryopreservation of cell-free lysates. The optimized vector solution and cryopreservation technology from Fraunhofer IME has been specifically developed to meet the wide application areas LenioBio is targeting.
With the addition of the Fraunhofer IME license, LenioBio is extending the patent family covering this innovative cell-free system.

30.7.2018

Fraunhofer ATTRACT Eco'n'OMICs started

 

On July 1st, the Fraunhofer ATTRACT Eco'n'OMICs started at the location Schmallenberg (Applied Ecology). The group works on OMICs based detection of ecotoxicological effects in the scope of screening series for active ingredient precursors of e.g. plant protection products. Head of the ATTRACT group is Dr. Sebastian Eilebrecht.

1.7.2018

Prof. Gerd Geißlinger appointed

 

On July 1st, the Executive Board of the Fraunhofer-Gesellschaft appointed Prof. Dr. Dr. Gerd Geißlinger as executive director of the Fraunhofer IME. Since January 2017, he has held this position as acting executive director. He is also Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology at the Johann Wolfgang Goethe University Frankfurt am Main.

Prof. Dr. Stefan Schillberg and Prof. Dr. Christoph Schäfers will continue to be acting members of the institute's management.

11.6.2018

Jacobs University and IME signed MoU

 

Jacobs University Bremen and the Fraunhofer Institute for Molecular Biology
and Applied Ecology IME, today announce their intention to set up a new
strategic collaboration to establish joint research projects in the area of antibiotic
drug discovery and promote the exchange of students, researchers and
educators between the institutions.

9.5.2018

Plants for pharmaceutical industry 4.0

 

The Fraunhofer IME presented a living exhibit and its digital twin at the joint Fraunhofer booth “Future Factory” at the Hanover Trade Fair 2018.

The living exhibit attracted many visitors at the Hanover Trade Fair from 23rd to 27th April. For most, the use of plants to produce protein-based pharmaceuticals was new territory. Fraunhofer IME is one of the pioneers in research on „Plant-made Pharmaceuticals“ in Germany. Plant biotechnologists transform plants into protein factories whose cells produce the desired proteins - simply, quickly and safely.

4.4.2018

International scientific conference “NanoGRAVUR”, Berlin, May 3-4, 2018

We invite to the Final Conference of “NanoGRAVUR“, a joint project funded by the Federal Ministry of Education and Research.

May 3rd: Final conference "Scientific achievements and regulatory needs for "grouping" of nanomaterials."
Target Group: (Young) scientists, experienced regulators, users

May 4th:  Workshop "Dissemination: Applicability and implementation of the 'nanoGRAVUR' concepts" under participation of Fraunhofer IME. Target Group: Public bodies, Ministries and Industry (in German)

More Information

3.8.2017

Evotec AG and IME sign strategic collaboration

 

Human stem cells, which can be produced from mature cells by dialing back their developmental programming - so-called "induced pluripotent stem cells (iPS cells)" - have enormous potential for regenerative medicine as well as for the research and development of new therapeutics. To ensure the development of better drug candidates in the field of patient-derived iPS cells, Evotec AG and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME are entering into a strategic alliance.

30.6.2017

4th Annual G20 World Brain Mapping Summit/Neuroscience-20 in Hamburg

On July 5, the 4th Annual G20 World Brain Mapping Summit / Neuroscience-20 will take place in Hamburg.

The aim of the Summit is to further develop activities in neuroscientific research projects to map the human brain and to unite the best scientists, engineers, doctors and surgeons worldwide in the fight against neurological disorders.